TMO
Thermo Fisher Scientific Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #156
- Final score
- 63.23
- Years on list
- 7
Flat trajectory
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
Flat trajectory
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 177 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 98 since 2020
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | TMO | WAT | BIIB |
|---|---|---|---|
| Climate Change | 72.7 | 75.8 | 86.3 |
| Employee Relations | 56.7 | 58.4 | 57.0 |
| Environment | 61.1 | 63.7 | 57.7 |
| Stakeholders & Society | 63.5 | 79.3 | 57.1 |
| Human Rights | 74.2 | 46.9 | 56.0 |
| Governance | 45.7 | 48.2 | 48.9 |
| Performance Rating | 63.0 | 53.1 | 64.2 |